{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T22:47:58Z","timestamp":1778107678611,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2004,11,1]],"date-time":"2004-11-01T00:00:00Z","timestamp":1099267200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacology Biochemistry and Behavior"],"published-print":{"date-parts":[[2004,11]]},"DOI":"10.1016\/j.pbb.2004.09.008","type":"journal-article","created":{"date-parts":[[2004,10,26]],"date-time":"2004-10-26T11:30:54Z","timestamp":1098790254000},"page":"547-553","source":"Crossref","is-referenced-by-count":63,"title":["Absence seizures in succinic semialdehyde dehydrogenase deficient mice: a model of juvenile absence epilepsy"],"prefix":"10.1016","volume":"79","author":[{"given":"M.A.","family":"Cortez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.M.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"III","given":"O.C.","family":"Snead","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.pbb.2004.09.008_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000117429","article-title":"Prognostic factors for childhood and juvenile absence epilepsies","volume":"37","author":"Bartolomei","year":"1997","journal-title":"Eur. Neurol."},{"key":"10.1016\/j.pbb.2004.09.008_bib2","first-page":"1570","article-title":"A high-affinity, Na+-dependent uptake system for gamma-hydroxybutyrate in membrane vesicles prepared from rat brain","volume":"38","author":"Benavides","year":"1982","journal-title":"J. Neurol."},{"key":"10.1016\/j.pbb.2004.09.008_bib3","series-title":"Gamma-hydroxybutyrate","first-page":"28","article-title":"Part of the pharmacological actions of gamma-hydroxybutyrate are mediated by GABAB receptors","author":"Bernasconi","year":"2002"},{"key":"10.1016\/j.pbb.2004.09.008_bib4","article-title":"Altered GABAB receptor (GABABxR) function and lethal status epilepticus in mice deficient for succinic semialdehyde dehydrogenase","author":"Buzzi","year":"2003","journal-title":"Abstr. - Soc. Neurosci."},{"key":"10.1016\/j.pbb.2004.09.008_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1212\/WNL.56.3.341","article-title":"A model of atypical absence seizures: EEG, pharmacology and developmental characterization","volume":"56","author":"Cortez","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/j.pbb.2004.09.008_bib6","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nrn811","article-title":"Childhood absence epilepsy: genes, channels, neurons and networks","volume":"3","author":"Crunelli","year":"2002","journal-title":"Nat. Rev., Neurosci."},{"key":"10.1016\/j.pbb.2004.09.008_bib7","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0006-8993(89)90399-5","article-title":"Suppressive effects of intranigral injection of muscimol in three models of generalized non-convulsive epilepsy induced by chemical agents","volume":"498","author":"Depaulis","year":"1989","journal-title":"Brain Res."},{"key":"10.1016\/j.pbb.2004.09.008_bib8","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/j.clinph.2004.01.002","article-title":"Photosensitive absence epilepsy with myoclonias and heterozygosity for succinic semialdehyde dehydrogenase (SSADH) deficiency","volume":"1153","author":"Dervent","year":"2004","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.pbb.2004.09.008_bib9","series-title":"The mouse brain in stereotaxic coordinates","author":"Franklin","year":"1997"},{"key":"10.1016\/j.pbb.2004.09.008_bib10","doi-asserted-by":"crossref","first-page":"11469","DOI":"10.1523\/JNEUROSCI.23-36-11469.2003","article-title":"Pathway-specific action of gamma-hydroxybutyric acid in sensory thalamus and its relevance to absence seizures","volume":"23","author":"Gervasi","year":"2003","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2004.09.008_bib11","first-page":"2079","article-title":"Disorders of beta- and gamma-amino acids in free and peptide-linked forms","volume":"vol. 91","author":"Gibson","year":"2001"},{"key":"10.1016\/j.pbb.2004.09.008_bib12","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/0009-8981(83)90018-9","article-title":"Succinic semialdehyde dehydrogenase deficiency: an inborn error of gamma amino butyric acid metabolism","volume":"133","author":"Gibson","year":"1983","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.pbb.2004.09.008_bib13","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1542\/peds.99.4.567","article-title":"The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients","volume":"99","author":"Gibson","year":"1997","journal-title":"Pediatrics"},{"key":"10.1016\/j.pbb.2004.09.008_bib14","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1046\/j.1471-4159.2002.00784.x","article-title":"Focal neurometabolic alterations in mice deficient for succinate semialdehyde dehydrogenase","volume":"81","author":"Gibson","year":"2002","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.09.008_bib15","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1111\/j.1471-4159.1977.tb10670.x","article-title":"Kinetics of in vivo conversion of gamma-[3H] aminobutyric acid to gamma-[3H] hydroxybutyric acid by rat brain","volume":"28","author":"Gold","year":"1977","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.09.008_bib16","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1124\/jpet.302.1.180","article-title":"Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria)","volume":"302","author":"Gupta","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.pbb.2004.09.008_bib17","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1038\/ng727","article-title":"Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase","volume":"29","author":"Hogema","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.pbb.2004.09.008_bib18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1042\/bj20020342","article-title":"Novel homodimeric and heterodimeric rat \u03b3-hydroxybutyrate synthetases that associate with the golgi apparatus define a distinct subclass of aldo-keto reductase 7 proteins","volume":"366","author":"Kelly","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.pbb.2004.09.008_bib19","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1111\/j.1528-1157.1995.tb01060.x","article-title":"Absence epilepsies","volume":"36","author":"Loiseau","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2004.09.008_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0920-1211(96)00022-8","article-title":"The role of technical, biological and pharmacological factors in the laboratory evaluation of anticonvulsant drugs: VI. Seasonal influences on maximal electroshock and pentylenetetrazole seizure thresholds","volume":"25","author":"Loscher","year":"1996","journal-title":"Epilepsy Res."},{"key":"10.1016\/j.pbb.2004.09.008_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0301-0082(96)00064-0","article-title":"The \u03b3-hydroxybutyrate signaling system in brain: organization and functional implications","volume":"51","author":"Maitre","year":"1997","journal-title":"Progr. Neurobiol."},{"key":"10.1016\/j.pbb.2004.09.008_bib22","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/BF00919710","article-title":"Clinical and genetic aspects of juvenile absence epilepsy","volume":"241","author":"Obeid","year":"1994","journal-title":"J. Neurol."},{"key":"10.1016\/j.pbb.2004.09.008_bib23","series-title":"Epilepsy: A Comprehensive Textbook","first-page":"2327","article-title":"Absence epilepsies","author":"Panayiotopoulos","year":"1997"},{"key":"10.1016\/j.pbb.2004.09.008_bib24","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1212\/01.WNL.0000059549.70717.80","article-title":"Clinical spectrum of succinic semialdehyde deficiency","volume":"60","author":"Pearl","year":"2003","journal-title":"Neurology"},{"issue":"Suppl. 6","key":"10.1016\/j.pbb.2004.09.008_bib25","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/ana.10629","article-title":"Succinic semialdehyde dehydrogenase deficiency in children and adults","volume":"54","author":"Pearl","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pbb.2004.09.008_bib26","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1111\/j.1528-1157.1988.tb03732.x","article-title":"Gamma-hydroxybutyrate model of generalized absence seizures: further characterization and comparison with other absence models","volume":"29","author":"Snead","year":"1988","journal-title":"Epilepsia"},{"key":"10.1016\/j.pbb.2004.09.008_bib27","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/0028-3908(91)90199-L","article-title":"The gamma-hydroxybutyrate model of absence seizures: correlation of regional brain levels of gamma-hydroxybutyric acid and gamma-butyrolactone with spike wave discharges","volume":"30","author":"Snead","year":"1991","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2004.09.008_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/0091-3057(95)00200-6","article-title":"Antiabsence seizure activity of specific GABAB and \u03b3-hydroxybutyric acid receptor antagonists","volume":"53","author":"Snead","year":"1996","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.pbb.2004.09.008_bib29","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1046\/j.1471-4159.2000.0751986.x","article-title":"Evidence for a G protein-coupled gamma-hydroxybutyric acid receptor","volume":"75","author":"Snead","year":"2000","journal-title":"J. Neurochem."},{"key":"10.1016\/j.pbb.2004.09.008_bib30","series-title":"Gamma hydroxybutyrate","first-page":"132","article-title":"\u03b3-Hydroxybutyric acid and absence seizure activity","author":"Snead","year":"2002"},{"key":"10.1016\/j.pbb.2004.09.008_bib31","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0028-3908(93)90163-W","article-title":"GABAA receptor function in the gamma-hydroxybutyrate model of generalized absence seizures","volume":"32","author":"Snead","year":"1993","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pbb.2004.09.008_bib32","first-page":"253","article-title":"Absence epilepsy: advances in experimental animal models","volume":"79","author":"Snead","year":"1999","journal-title":"Adv. Neurol."},{"key":"10.1016\/j.pbb.2004.09.008_bib33","doi-asserted-by":"crossref","first-page":"6218","DOI":"10.1523\/JNEUROSCI.20-16-06218.2000","article-title":"Modulation of absence seizures by the GABA(A) receptor: a critical role for metabotropic glutamate receptor 4 (mGluR4)","volume":"15","author":"Snead","year":"2000","journal-title":"J. Neurosci."},{"key":"10.1016\/j.pbb.2004.09.008_bib34","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0300-9629(95)00099-2","article-title":"gamma-Aminobutyric acid (GABA) metabolism in mammalian neural and nonneural tissues","volume":"112","author":"Tillakaratne","year":"1995","journal-title":"Comp. Biochem. Physiol., A. Physiol."},{"key":"10.1016\/j.pbb.2004.09.008_bib35","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1017\/S0317167100002560","article-title":"Natural history of absence epilepsy in children","volume":"30","author":"Wirrell","year":"2003","journal-title":"Can. J. Neurol. Sci."},{"issue":"Suppl. 6","key":"10.1016\/j.pbb.2004.09.008_bib36","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/ana.10696","article-title":"GABA, gamma-hydroxybutyric acid, and neurological disease","volume":"54","author":"Wong","year":"2003","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.pbb.2004.09.008_bib37","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.tips.2003.11.001","article-title":"From the street to the brain: neurobiology of the recreational drug \u03b3-hydroxybutyric acid","volume":"25","author":"Wong","year":"2004","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.pbb.2004.09.008_bib38","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1535-7597.2001.00009.x","article-title":"The GABAA receptor: subunit-dependent functions and absence seizures","volume":"1","author":"Wong","year":"2001","journal-title":"Epilepsy Curr."}],"container-title":["Pharmacology Biochemistry and Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704002989?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091305704002989?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T16:20:28Z","timestamp":1549124428000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091305704002989"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,11]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2004,11]]}},"alternative-id":["S0091305704002989"],"URL":"https:\/\/doi.org\/10.1016\/j.pbb.2004.09.008","relation":{},"ISSN":["0091-3057"],"issn-type":[{"value":"0091-3057","type":"print"}],"subject":[],"published":{"date-parts":[[2004,11]]}}}